design: Blood-derived DNA was obtained from a cohort of individuals with undiagnosed, possibly genetic, complex diseases. Some family members were included for segregation analysis as available and relevant. Analysis focused on detecting potential disease-causing variation. The cohort is highly heterogeneous reflecting the diverse study population and the rapid evolution of sequencing technology and availability at the time.